Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
GE HealthCare TechnologiesMEX:GEHC 63 Return-on-Tangible-Asset is 7.34% as of Mar. 2026, which is 44% below its 10-year median of 13.10. GuruFocus rates MEX:GEHC with a GF Score™ of 63/100 and a GF Value™ of MXN1,491.04 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 855 Medical Devices & Instruments companies, GE HealthCare Technologies ranks better than 79.77% on this metric.
Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. GE HealthCare Technologies's annualizedNet Income for the quarter that ended in Mar. 2026 was MXN28,059 Mil. GE HealthCare Technologies's average total tangible assets for the quarter that ended in Mar. 2026 was MXN382,389 Mil. Therefore, GE HealthCare Technologies's annualized Return-on-Tangible-Asset for the quarter that ended in Mar. 2026 was 7.34%.
The historical rank and industry rank for GE HealthCare Technologies's Return-on-Tangible-Asset or its related term are showing as below:
MEX:GEHC'
s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: 9.2 Med: 13.1 Max: 128.72
Current: 9.2
During the past 7 years, GE HealthCare Technologies's highest Return-on-Tangible-Asset was 128.72%. The lowest was 9.20%. And the median was 13.10%.
MEX:GEHC's Return-on-Tangible-Asset is ranked better than 79.77% of 855
companies
in the Medical Devices & Instruments industry
Industry Median: 0.62
vs MEX:GEHC: 9.20
GE HealthCare Technologies (MEX:GEHC) Return-on-Tangible-Asset Explanation
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companys earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companys tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
GE HealthCare Technologies Return-on-Tangible-Asset Related Terms
GE HealthCare Technologies Return-on-Tangible-Asset Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
GE HealthCare Technologies Return-on-Tangible-Asset Chart
MEX:GEHC vs DXCM, STE, ZBH: Return-on-Tangible-Asset Comparison
For the Medical Devices subindustry, GE HealthCare Technologies's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
GE HealthCare Technologies Return-on-Tangible-Asset vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, GE HealthCare Technologies's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where GE HealthCare Technologies's Return-on-Tangible-Asset falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Mar. 2026) net income data.
What does a Return-on-Tangible-Asset of 7.34% mean?
GE HealthCare Technologies (MEX:GEHC) has a Return-on-Tangible-Asset of 7.34% as of Mar. 2026. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on GE HealthCare Technologies and its competitors. This is 44% below median its historical median of 13.10. Over the past decade, GE HealthCare Technologies' Return-on-Tangible-Asset has ranged from 9.20 to 128.72. According to the industry distribution chart, GE HealthCare Technologies ranks #173 out of 855 companies in the Medical Devices & Instruments industry, placing it in the top 20.2%.
Is GE HealthCare Technologies' Return-on-Tangible-Asset too high?
GE HealthCare Technologies' current Return-on-Tangible-Asset of 7.34% is 44% below median its 10-year median of 13.10. Over the past 10 years, this metric has ranged from a low of 9.20 to a high of 128.72. The Medical Devices & Instruments industry median Return-on-Tangible-Asset is 0.62. GE HealthCare Technologies' value of 7.34% is 1083.9% above this industry median. Based on the distribution chart, GE HealthCare Technologies ranks #173 out of 855 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, GE HealthCare Technologies has a GF Score™ of 63/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does GE HealthCare Technologies' Return-on-Tangible-Asset compare to DXCM and STE?
According to the Medical Devices & Instruments industry distribution chart, GE HealthCare Technologies ranks #173 out of 855 companies for Return-on-Tangible-Asset. This places GE HealthCare Technologies in the top 20% of its industry — outperforming the majority of peers. The industry median Return-on-Tangible-Asset is 0.62. GE HealthCare Technologies' value of 7.34% is 1083.9% above this benchmark. Historically, GE HealthCare Technologies' own Return-on-Tangible-Asset has ranged from 9.20 to 128.72 over the past decade. While the company's 10-year median is 13.10 vs. the industry median of 0.62, GE HealthCare Technologies has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Medical Devices & Instruments company?
The median Return-on-Tangible-Asset among Medical Devices & Instruments companies is 0.62, based on 855 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Asset significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. GE HealthCare Technologies's current Return-on-Tangible-Asset of 7.34% is 1083.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on GE HealthCare Technologies and its competitors. For the Medical Devices & Instruments industry, the median Return-on-Tangible-Asset is 0.62 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. GE HealthCare Technologies's current Return-on-Tangible-Asset is 7.34%, which is 44% below median its own 10-year median of 13.10. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GE HealthCare Technologies stock overvalued right now?
Based on GuruFocus' analysis, GE HealthCare Technologies (MEX:GEHC) is currently considered Modestly Undervalued. The stock's GF Value™ is MXN1,491.04, compared to a current price of MXN1,094.87 — trading 26.6% below its estimated fair value. The current Return-on-Tangible-Asset is 7.34%, which is 44% below median its 10-year median of 13.10 and 1083.9% above the Medical Devices & Instruments industry median of 0.62. GE HealthCare Technologies' overall GF Score™ is 63/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For GE HealthCare Technologies (MEX:GEHC), the current Return-on-Tangible-Asset is 7.34% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is GE HealthCare Technologies (MEX:GEHC) Overvalued in 2026?
Based on GuruFocus' analysis, GE HealthCare Technologies stock appears to be undervalued.
The current stock price of MXN1,094.87 is trading 26.6% below its estimated GF Value™ of MXN1,491.04.
GuruFocus considers GE HealthCare Technologies to be Modestly Undervalued.
Key valuation signals for MEX:GEHC:
Return-on-Tangible-Asset: 7.34% (44% below median its 10-year median of 13.10)
GF Value™: MXN1,491.04 vs. price of MXN1,094.87 (26.6% below fair value)
Industry Position: 1083.9% above the Medical Devices & Instruments median (#173 of 855)
No single metric tells the full story. See the MEX:GEHC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (15%), and pharmaceutical diagnostics (14%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 11%, and 17%, respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one-third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).
63GF Score
Get the complete analysis for MEX:GEHC
Return-on-Tangible-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:GEHC has been successfully added to your 
